One of the makers of the COVID vaccine, Pfizer Inc, has announced plans to purchase Biohaven Pharmaceutical Holding Co. The company revealed their intensions of paying $11.6 billion to tap into the migraine medicine market. The buyout was approved by the boards of both companies. The migraine medicine company’s shares jumped 70% to $141.31 apiece. […]
It is estimated that nearly 50 million Americans are affected by severe headaches and/or migraines on a regular basis. Migraines alone affect approximately 10 percent of the U.S. population and result in $1 billion a year in medical costs. However, there are ways to alleviate and treat these attacks. Here are some secrets to migraine […]
Migraine headaches affect about 36 million Americans. The throbbing, light sensitivity and other symptoms can be debilitating, but there is new hope for migraine sufferers via a minimally invasive treatment. Researchers in New York have been working on a new intervention for patients dealing with recurring migraines. To help prevent painful recurrences of migraine symptoms, […]
